High profile politicians have thrown their weight behind calls to screen at-risk men for prostate cancer, but are potential ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...

Eric Morrow had a family history of prostate cancer, but because he was not yet 55, they wouldn't screen him. However, a ...

Managing prostate cancer still begins at your doctor's office, but today we know that when it comes to treating and preventing disease, nutrition plays a role. Research confirms an association ...

My doctor was of the opinion that over-medicalisation of patients was a common problem, and that a high PSA reading might ...

(UroToday.com) The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by Dr. Channing Paller discussing germline and somatic genetic ...